BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Innova Biosciences: Lightning-Link(TM) Strikes in China


3/1/2010 1:09:27 PM

A Cambridge company is taking its revolutionary antibody labelling kit into China following timely support from UK Trade and Investment (UKTI).

Already a pioneer in the field of antibody labelling, Innova Biosciences Ltd has been able to appoint two new distributors in Genetimes Technology Inc and NeoBioscience Technology Company.

The company, based at the Babraham Institute, first opened its research laboratories in October 2002 and was quickly awarded a research grant the following year to develop a number of novel research products primarily for applications in the pharmaceutical sector.

Following the development of Lightning-Link™ in 2006, the World?s easiest to use antibody labelling kit, Innova dramatically changed direction.

As well as being used in hospital and research labs around the world, the kit also features in consumer items such as pregnancy test kits.

With the product being sold throughout the Life Science sector, Innova is now positioned as a world leader in the supply of products and services to the academic, pharmaceutical and diagnostics sectors.

So, when interest began to spark in China, the company turned to UKTI for advice. Sales Director, Tim Bernard, explains. We knew we needed some help and advice to tackle a totally unfamiliar market and that is where we came into contact with UKTI?s Chris Ilsley. We were getting lots of hits to the website from scientists in China but didn?t have the solution as to how to follow these up.

Tim explained: „Thanks to the support from UKTI, I was able to visit Shanghai, Hong Kong and Beijing and make some invaluable contacts as well as fully understanding what initially appeared, quite a complex market.

Through Chris we came to realise just how much help is available. We now know how we can get the right information on a new market and that it will be reliable. We know that it is vital to understand the market; that each is different and that you need to appreciate the cultural aspects as well as the economic and legal niceties. I found our interaction with UKTI thoroughly excellent.? „Tim and his company are a great example to other potential exporters”, says Chris Ilsley, International Trade Adviser with responsibility for the Biotech and Pharmaceutical sectors. “They have taken what was a challenging situation and turned it into a positive. They came to us to see how we could help in China and made use of our Export Marketing Research Scheme (EMRS).? The EMRS service enables potential exporters to obtain tailored intelligence on topics such as market size and segmentation, regulations and legislation, customer needs, distribution channels, trends and competitor activity.

About the company:

Innova Biosciences is a growing, dynamic business, based in Cambridge, UK. At the core of Innova?s business is the Lightning-Link™, an innovative technology that simplifies production of labeled antibodies for use in R&D applications, drug discovery and diagnostics. The expanding Lightning-Link™ portfolio currently consists of 44 individual products and is sold to research laboratories in over 30 countries around the world.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES